David Mayhew, MD, PhD
Harvard University
H-index: 16
North America-United States
Top articles of David Mayhew, MD, PhD
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system | JCI insight | Jonathan So Nathaniel W Mabe Bernhard Englinger Kin-Hoe Chow Sydney M Moyer | 2022/10/10 |
Structure–function analysis of the SHOC2–MRAS–PP1C holophosphatase complex | Nature | Jason J Kwon Behnoush Hajian Yuemin Bian Lucy C Young Alvaro J Amor | 2022/9/8 |
Abstract LB029: Comprehensive structure-function evaluation of the SHOC2 holophosphatase reveals disease mechanisms and therapeutic opportunities | Cancer Research | Jason Kwon Behnoush Hajian Yuemin Bian Alvaro Amor James Fuller | 2022/6/15 |
VRK1 is required in VRK2-methylated cancers of the nervous system | bioRxiv | Jonathan So Nathaniel W Mabe Bernhard Englinger Sydney M Moyer Maria C Trissal | 2021/12/30 |
RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics | The Journal of Clinical Investigation | Raie T Bekele Amruta S Samant Amin H Nassar Jonathan So Elizabeth P Garcia | 2021/11/15 |
Genomic Amplification and Functional Dependency of the Gamma Actin Gene ACTG1 in Uterine Cancer | International journal of molecular sciences | Camden Richter David Mayhew Jonathan P Rennhack Jonathan So Elizabeth H Stover | 2020/11/18 |
